Updated:
Elevation Oncology, Inc.
Elevation Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001783032, and its reported...
Overview
Elevation Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001783032, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-06, it reported net income of USD -44,485,000; total assets of USD 95,626,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Elevation Oncology, Inc.
- Former names in filing history
- 14ner Oncology, Inc. (2019-07-19 to 2019-07-19)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001783032
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$44.5M | $95.6M | $49.5M | -$36.4M | |
| FY2023USD | -$45.7M | $89.1M | $49.3M | -$56.2M | |
| FY2022USD | -$95.1M | $94.2M | $45.9M | -$85.5M | |
| FY2021USD | -$32.0M | $149.5M | $146.3M | -$30.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Elevation Oncology, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.